Article & Resources
BXTAccelyon verhoogt opnieuw zijn inzet voor Europese expansie met een nieuwe locatie in Nederland
BXTAccelyon increases commitment to European expansion with new locations in the Netherlands
BAUN Conference highlight: “Nurses are key to eradicating transrectal prostate biopsy”
Un nouveau rapport indépendant du York Health Economics Consortium (YHEC) sur les biopsies du cancer de la prostate a validé l’amélioration des résultats pour la santé et les avantages économiques de la méthodologie PrecisionPointTM de biopsie transpérinéale de la prostate sous anesthésie locale (TP AL).
My dad had prostate cancer when he was 65. Does this make me more likely to get it too? What could increase my risk and how will I know if I have it?
Like Bill Turnbull and Stephen Fry, Russell is keen to make more men aware of the importance of getting themselves checked early and regularly.
David Robb was a 68-year-old retired secondary school teacher from Peebles, Scotland when he was diagnosed with prostate cancer last Summer.
All men with suspected prostate cancer should be offered a specialist MRI scan when they’re referred to the hospital in England, before a biopsy.
BXTAccelyon addresses concerns that patients may be misled by news of HDR brachytherapy monotreatment
Chris was diagnosed with prostate cancer at the age of 67, having previously been treated for testicular cancer in 1976. His treatment pathway took many turns and below is his story.
Kevin Darragh began his prostate cancer treatment journey back in December 2012. After researching and discussing treatment options with those close to him, Kevin decided on brachytherapy
John Morris’ story is an example of how far prostate cancer diagnosis and treatment, as well as men’s attitudes to the disease, have evolved in the last 10 years. It also proves the validity of low dose rate brachytherapy (LDR-B) as a long-standing, clinically proven treatment option with minimal quality of live side effects compared to other treatments
Edinburgh Cancer Centre: supporting open thinking in prostate cancer treatment options
Sorry, there are currently no posts with that category.